Perspectives in vascular surgery and endovascular therapy最新文献_第5页

A 6-year experience treating vascular malformations with foam sclerotherapy. 用泡沫硬化疗法治疗血管畸形6年经验。

Perspectives in vascular surgery and endovascular therapy Pub Date : 2012-06-01 Epub Date: 2012-08-22 DOI: 10.1177/1531003512457205

Jovan N Markovic, Charles Y Kim, Michael E Lidsky, Cynthia K Shortell

{"title":"A 6-year experience treating vascular malformations with foam sclerotherapy.","authors":"Jovan N Markovic, Charles Y Kim, Michael E Lidsky, Cynthia K Shortell","doi":"10.1177/1531003512457205","DOIUrl":"https://doi.org/10.1177/1531003512457205","url":null,"abstract":"In this study, the authors present an analysis of the outcomes of 105 low-flow vascular malformation patients treated over a 6-year period and report specific lesion characteristics that correlate with those vascular malformations that will benefit from sodium tetradecyl sulfate foam sclerotherapy (STS FS) versus surgical resection as well as morphological characteristics of vascular malformations that are associated with a poor response to FS treatment. Improvement in symptoms was documented in 92.9% of patients treated with STS FS. There were no complications. Low-flow vascular malformations that were morphologically characterized by microcystic, septated vessels did not respond to FS, and these vascular malformations are best treated with surgical resection. Primary surgical resection is also the treatment of choice for localized, microcystic, and superficial low-flow vascular malformations. Symptomatic, diffuse, extensive, macrocystic malformations that involve multiple tissue planes and vital structures are best treated with FS.","PeriodicalId":87201,"journal":{"name":"Perspectives in vascular surgery and endovascular therapy","volume":"24 2","pages":"70-9"},"PeriodicalIF":0.0,"publicationDate":"2012-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1531003512457205","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30855666","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 14

A retrospective study on the use of heparin for peripheral vascular intervention. 肝素用于周围血管介入治疗的回顾性研究。

Perspectives in vascular surgery and endovascular therapy Pub Date : 2012-06-01 Epub Date: 2012-10-24 DOI: 10.1177/1531003512459889

Stuart Walker, Charles Beasley, Mark Reeves

{"title":"A retrospective study on the use of heparin for peripheral vascular intervention.","authors":"Stuart Walker, Charles Beasley, Mark Reeves","doi":"10.1177/1531003512459889","DOIUrl":"https://doi.org/10.1177/1531003512459889","url":null,"abstract":"Purpose: To compare immediate outcomes for patients who receive and those who do not receive heparin during lower limb endovascular intervention.Methods: A retrospective case series of 330 procedures for lower limb peripheral arterial occlusive disease. Patient records were interrogated for bleeding or thrombotic/embolic complications during or immediately after endovascular intervention for peripheral arterial occlusive disease.Results: Of the 220 patients who received heparin, 21 (9.6%) suffered an access site bleed compared with 2 of the 110 patients (2%) who did not receive heparin (odds ratio [OR] = 5.7; 95% confidence interval [CI] = 1.3-25; P = .01). There were 6 embolic/thrombotic complications in the patients who received heparin (2.7%) compared with 4 in those that did not receive heparin (3.6%; P = .74). In 187 cases, a closure or compression device was used (StarClose, n = 109; Angio-Seal, n = 42; FemoStop, n = 35; ProGlide, n = 1), of which there were 3 access bleeding complications (2%). One hundred and forty-three cases did not have a closure or compression device associated with 17 (12%) access bleeding complications (OR = 0.25; 95% CI = 0.09-0.64; P = .004).Conclusions: In this study, heparin use and nonuse of a closure or compression device was associated with an increased risk of access site bleeding. Embolic/thrombotic complications were uncommon.","PeriodicalId":87201,"journal":{"name":"Perspectives in vascular surgery and endovascular therapy","volume":"24 2","pages":"63-9"},"PeriodicalIF":0.0,"publicationDate":"2012-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1531003512459889","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31004618","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 7

Hepatic artery transection reconstructed with splenic artery transposition graft. 脾动脉转位重建肝动脉横断。

Perspectives in vascular surgery and endovascular therapy Pub Date : 2012-06-01 Epub Date: 2012-07-23 DOI: 10.1177/1531003512454580

Jason Faulds, Amanda Johner, Darren Klass, Andrzej Buczkowski, Charles H Scudamore

{"title":"Hepatic artery transection reconstructed with splenic artery transposition graft.","authors":"Jason Faulds, Amanda Johner, Darren Klass, Andrzej Buczkowski, Charles H Scudamore","doi":"10.1177/1531003512454580","DOIUrl":"https://doi.org/10.1177/1531003512454580","url":null,"abstract":"Introduction: Hepatic artery transection presents a technical challenge in vascular reconstruction. Formal arterial repair is indicated in patients with underlying liver disease and those undergoing bile duct reconstructions because of a higher risk of complication following hepatic artery injury. This report highlights a novel approach to hepatic artery transection with splenic artery transposition.Methods: A case of hepatic artery transection repaired with splenic artery transposition is presented with an accompanying literature review.Results: During elective pancreaticoduodenectomy, the common hepatic artery was injured at its origin. The splenic artery was divided and transposed to the hepatic artery, thus restoring arterial flow to the liver and bile duct.Conclusion: Various strategies to manage a hepatic artery injury have been described, ranging from ligation to complex vascular reconstruction. In hemodynamically stable patients, arterial transposition using the splenic artery is a feasible method to ensure adequate arterial supply to the liver and biliary tract.","PeriodicalId":87201,"journal":{"name":"Perspectives in vascular surgery and endovascular therapy","volume":"24 2","pages":"87-9"},"PeriodicalIF":0.0,"publicationDate":"2012-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1531003512454580","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30784107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 10

Resection of a giant primary synovial sarcoma of the inferior vena cava extending into the right atrium with caval reconstruction under cardiopulmonary bypass and circulatory arrest. 切除延伸至右心房的下腔静脉的巨大原发性滑膜肉瘤，在体外循环和循环停止下进行腔静脉重建。

Perspectives in vascular surgery and endovascular therapy Pub Date : 2012-06-01 DOI: 10.1177/1531003512468035

Kevin B Wise, Sameh M Said, Clancy J Clark, Scott H Okuno, Sejal S Shah, Soon J Park, David M Nagorney, Peter Gloviczki

{"title":"Resection of a giant primary synovial sarcoma of the inferior vena cava extending into the right atrium with caval reconstruction under cardiopulmonary bypass and circulatory arrest.","authors":"Kevin B Wise, Sameh M Said, Clancy J Clark, Scott H Okuno, Sejal S Shah, Soon J Park, David M Nagorney, Peter Gloviczki","doi":"10.1177/1531003512468035","DOIUrl":"https://doi.org/10.1177/1531003512468035","url":null,"abstract":"Background: Synovial sarcoma primarily arises in para-articular locations of the extremities. However, numerous unique sites of origin have been reported. There are only 5 known cases of primary intravascular synovial sarcoma.Methods: We present the second reported case of synovial sarcoma arising from the inferior vena cava (IVC) in a 41-year-old woman with progressive fatigue, abdominal distension, and lower-extremity swelling. This is the first known case with a monophasic histological subtype.Results: The tumor arose from the retrohepatic IVC with cephalad extension into the right atrium. Excision required cardiopulmonary bypass and deep hypothermic circulatory arrest, followed by bovine pericardial patch reconstruction of the IVC.Conclusions: Primary synovial sarcoma of the IVC is rare. The use of cardiopulmonary bypass with or without deep hypothermic circulatory arrest may be required if there is tumor extension into the heart. Bovine pericardium is an excellent material for caval reconstruction.","PeriodicalId":87201,"journal":{"name":"Perspectives in vascular surgery and endovascular therapy","volume":" ","pages":"95-101"},"PeriodicalIF":0.0,"publicationDate":"2012-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1531003512468035","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40206341","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 10

Long-term results of carotid artery stenting in patients 80 years and older. 颈动脉支架置入术对80岁及以上患者的远期疗效。

Perspectives in vascular surgery and endovascular therapy Pub Date : 2012-06-01 Epub Date: 2012-09-09 DOI: 10.1177/1531003512459913

Daniela Mazzaccaro, Maria Teresa Occhiuto, Silvia Stegher, Giovanni Malacrida, Marco Caldana, Domenico G Tealdi, Giovanni Nano

{"title":"Long-term results of carotid artery stenting in patients 80 years and older.","authors":"Daniela Mazzaccaro, Maria Teresa Occhiuto, Silvia Stegher, Giovanni Malacrida, Marco Caldana, Domenico G Tealdi, Giovanni Nano","doi":"10.1177/1531003512459913","DOIUrl":"https://doi.org/10.1177/1531003512459913","url":null,"abstract":"Introduction: We report our experience about carotid artery stenting (CAS) in patients 80 years and older.Materials and methods: Out of 582 patients who underwent CAS at our institution from January 1999 to June 2010, 102 patients (group A) were 80 years or older. The clinical data of these patients were retrospectively reviewed, outcomes analyzed, and compared with those of younger patients who underwent CAS during the same period (group B).Results: Outcomes of group B were similar to those of group A, both at 30 days and at long term. Male gender, symptoms, and not using an embolic protection device were related to long-term complications in both groups. Occurrence of bradycardia/asystole during CAS was a risk factor for long-term myocardial infarction for group A only.Conclusions: CAS can be safely performed in patients 80 years or older, with results that compare favorably to those of younger patients.","PeriodicalId":87201,"journal":{"name":"Perspectives in vascular surgery and endovascular therapy","volume":"24 2","pages":"49-54"},"PeriodicalIF":0.0,"publicationDate":"2012-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1531003512459913","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30895465","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 2

Computer-aided surgery: concepts and applications in vascular surgery. 计算机辅助手术:血管手术的概念和应用。

Perspectives in vascular surgery and endovascular therapy Pub Date : 2012-03-01 Epub Date: 2012-04-18 DOI: 10.1177/1531003512442092

Adrien Kaladji, Antoine Lucas, Alain Cardon, Pascal Haigron

引用次数: 13

Comparison of the novel Angio-Seal Evolution with Angio-Seal STS closure device. 新型Angio-Seal Evolution与ango - seal STS闭合装置的比较。

Perspectives in vascular surgery and endovascular therapy Pub Date : 2012-03-01 Epub Date: 2012-04-03 DOI: 10.1177/1531003512442091

Alessandro Lupi, Andrea Rognoni, Gioel G Secco, Maurizio Lazzero, Laura Plebani, Giuseppe Cossa, Danilo Reale, Mara Sansa, Angelo S Bongo, Carlo Di Mario

{"title":"Comparison of the novel Angio-Seal Evolution with Angio-Seal STS closure device.","authors":"Alessandro Lupi, Andrea Rognoni, Gioel G Secco, Maurizio Lazzero, Laura Plebani, Giuseppe Cossa, Danilo Reale, Mara Sansa, Angelo S Bongo, Carlo Di Mario","doi":"10.1177/1531003512442091","DOIUrl":"https://doi.org/10.1177/1531003512442091","url":null,"abstract":"Background: Angio-Seal Evolution (ASE) is a novel vascular closure device (VCD) engineered to reduce deployment skills. It is unknown if these changes translated into better clinical results.Methods and results: Early VCD failure and major and minor vascular complications were prospectively assessed in 584 consecutive patients treated by ASE (ASE group) and in 633 consecutive patients treated by the older Angio-Seal STS (AS-STS group). Early VCD failure was rare (ASE 1.7% vs AS-STS 1.3%, P = .52). Major vascular complication risk was similar (odds ratio [OR] = 1.76, 95% confidence interval [CI] = 0.79-3.90, P = .17), but minor vascular complication rate was significantly higher in the ASE group (OR = 3.36, 95% CI = 1.57-7.21, P = .002). At logistic regression ASE was an independent predictor of vascular complications. Early VCD failure was associated with the highest risk for vascular complications.Conclusions: In a large unselected population, ASE-treated patients showed increased risk for minor vascular complications. Early VCD failure negatively affected short-term vascular prognosis.","PeriodicalId":87201,"journal":{"name":"Perspectives in vascular surgery and endovascular therapy","volume":"24 1","pages":"28-36"},"PeriodicalIF":0.0,"publicationDate":"2012-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1531003512442091","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30565689","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 3

Epidermal growth factor in the treatment of diabetic foot ulcers: an update. 表皮生长因子治疗糖尿病足溃疡:最新进展。

Perspectives in vascular surgery and endovascular therapy Pub Date : 2012-03-01 Epub Date: 2012-04-11 DOI: 10.1177/1531003512442093

Elisavet K Tiaka, Nikolaos Papanas, Anastassios C Manolakis, George S Georgiadis

{"title":"Epidermal growth factor in the treatment of diabetic foot ulcers: an update.","authors":"Elisavet K Tiaka, Nikolaos Papanas, Anastassios C Manolakis, George S Georgiadis","doi":"10.1177/1531003512442093","DOIUrl":"https://doi.org/10.1177/1531003512442093","url":null,"abstract":"Management of diabetic foot ulcers remains a rather challenging task. Epidermal growth factor (EGF) plays a central role in wound healing. It acts on epithelial cells and fibroblasts promoting restoration of damaged epithelium. However, its bioavailability is impaired in chronic diabetic foot ulcers. Current evidence suggests that application of human recombinant EGF in addition to standard treatment is able to achieve both partial and complete healing and to prevent foot amputations. Its efficacy has been tested at various concentrations and by various administration routes (topical application and intralesional injection). Intralesional injection has better availability on the deep wound layers, but pain at the injection site is a common complaint. Generally, adverse events have been minor to mild. Finally, numerous issues need to be further clarified before widespread use of EGF becomes possible in everyday practice. Such issues include optimal dosage and administration route, characteristics of the ulcers most likely to heal (severity and ischemic/neuropathic or both), and cost-effectiveness.","PeriodicalId":87201,"journal":{"name":"Perspectives in vascular surgery and endovascular therapy","volume":"24 1","pages":"37-44"},"PeriodicalIF":0.0,"publicationDate":"2012-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1531003512442093","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30569276","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 80

Current role and future directions of hybrid repair of thoracoabdominal aortic aneurysms. 胸腹主动脉瘤混合修复的现状及未来发展方向。

Perspectives in vascular surgery and endovascular therapy Pub Date : 2012-03-01 DOI: 10.1177/1531003512445808

Gustavo S Oderich, Bernardo C Mendes, Peter Gloviczki, Manju Kalra, Audra A Duncan, Thomas C Bower

引用次数: 19

Clinical outcome of staged versus combined treatment approach of hybrid repair of thoracoabdominal aortic aneurysm with visceral vessel debranching and aortic endograft exclusion. 分阶段与联合治疗胸腹主动脉瘤联合内脏血管去分支及主动脉内植物排除的临床疗效。

Perspectives in vascular surgery and endovascular therapy Pub Date : 2012-03-01 Epub Date: 2012-02-08 DOI: 10.1177/1531003511432768

Peter H Lin, Panagiotis Kougias, Carlos F Bechara, Sarah M Weakley, Faisal G Bakaeen, Scott A Lemaire, Joseph S Coselli

{"title":"Clinical outcome of staged versus combined treatment approach of hybrid repair of thoracoabdominal aortic aneurysm with visceral vessel debranching and aortic endograft exclusion.","authors":"Peter H Lin, Panagiotis Kougias, Carlos F Bechara, Sarah M Weakley, Faisal G Bakaeen, Scott A Lemaire, Joseph S Coselli","doi":"10.1177/1531003511432768","DOIUrl":"https://doi.org/10.1177/1531003511432768","url":null,"abstract":"Although visceral vessel debranching and endovascular aneurysm exclusion represents a hybrid treatment approach in patients with thoracoabdominal aortic aneurysm, the effect of timing with regard to the visceral debranching procedure and endovascular aneurysm exclusion in this treatment strategy remains unclear. In this study, the authors analyzed their recent institutional experience of visceral debranching and aneurysm stent-grafting procedures. Specifically, the authors compared the effect of staged (n = 27) versus combined (n = 31) hybrid treatment in patients with complex aortic aneurysms. This study showed a higher incidence of renal insufficiency in patients undergoing a combined hybrid repair than the staged hybrid approach. The possibility of aneurysm rupture may exist in the staged treatment approach if the duration of staged repair is prolonged. The combined hybrid treatment strategy should be performed with caution as it is associated with significantly higher complication rates than the staged hybrid treatment modality.","PeriodicalId":87201,"journal":{"name":"Perspectives in vascular surgery and endovascular therapy","volume":"24 1","pages":"5-13"},"PeriodicalIF":0.0,"publicationDate":"2012-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1531003511432768","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30444963","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 49